Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Fixed-dose losartan/hydrochlorothiazide combination now available in U.K.

July 8, 1997

Potent, selective and orally active ETA antagonist from Zeneca

July 8, 1997

Agent for restenosis in preclinical development at CV Therapeutics

July 7, 1997

New cardiovascular agent in development at CV Therapeutics

July 7, 1997

New agents for tachycardia from CV Therapeutics

July 7, 1997

RPR licenses Dilacor XR to Watson

July 7, 1997

Sublingual captopril and nifedipine compared in patients with hypertensive crises

July 7, 1997

Garlic has beneficial effects in model of volume overload heart failure

July 7, 1997

Roche's T-type calcium channel blocker receives European approval

July 3, 1997

Novel antifibrillatory agent: DP-16

July 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...